Cargando…

JMJD6 Regulates ERα Methylation on Arginine

ERα functions are tightly controlled by numerous post-translational modifications including arginine methylation, which is required to mediate the extranuclear functions of the receptor. We report that upon oestrogenic stimulation, JMJD6, the only arginine demethylase described so far, interacts wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poulard, Coralie, Rambaud, Juliette, Hussein, Nader, Corbo, Laura, Le Romancer, Muriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912157/ https://www.ncbi.nlm.nih.gov/pubmed/24498420 http://dx.doi.org/10.1371/journal.pone.0087982

Ejemplares similares

Role of JMJD6 in Breast Tumourigenesis
por: Poulard, Coralie, et al.
Publicado: (2015)

Protein arginine methylation/demethylation and cancer
por: Poulard, Coralie, et al.
Publicado: (2016)

The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer
por: Choucair, Ali, et al.
Publicado: (2019)

The Novel Protease Activities of JMJD5–JMJD6–JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled
por: Liu, Haolin, et al.
Publicado: (2022)

ERα-36 regulates progesterone receptor activity in breast cancer
por: Konan, Henri-Philippe, et al.
Publicado: (2020)

Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?
por: Mery, Benoîte, et al.
Publicado: (2021)

Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7
por: Liu, Haolin, et al.
Publicado: (2018)

PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer
por: Malbeteau, Lucie, et al.
Publicado: (2022)

How Protein Methylation Regulates Steroid Receptor Function
por: Malbeteau, Lucie, et al.
Publicado: (2021)

Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer
por: Noureddine, Lara Malik, et al.
Publicado: (2021)

PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor
por: Malbeteau, Lucie, et al.
Publicado: (2020)

The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer
por: Omarjee, S, et al.
Publicado: (2017)

PRMT5 prognostic value in cancer
por: Lattouf, Hanine, et al.
Publicado: (2019)

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα (+) breast cancer
por: Poulard, Coralie, et al.
Publicado: (2023)

Structure, Activity, and Function of PRMT1
por: Thiebaut, Charlène, et al.
Publicado: (2021)

Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
por: Teinturier, Romain, et al.
Publicado: (2021)

Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a
por: Poulard, Coralie, et al.
Publicado: (2021)

Activation of rapid oestrogen signalling in aggressive human breast cancers
por: Poulard, Coralie, et al.
Publicado: (2012)

The Role of ERα36 in Development and Tumor Malignancy
por: Thiebaut, Charlène, et al.
Publicado: (2020)

Protein arginine methyltransferase 6 mediates cardiac hypertrophy by differential regulation of histone H3 arginine methylation
por: Raveendran, Vineesh Vimala, et al.
Publicado: (2020)

JMJD6 orchestrates a transcriptional program in favor of endocrine resistance in ER+ breast cancer cells
por: Das, Partha, et al.
Publicado: (2022)

JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner
por: Yi, Jia, et al.
Publicado: (2017)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer
por: Noureddine, Lara Malik, et al.
Publicado: (2023)

Jmjd6 regulates ES cell homeostasis and enhances reprogramming efficiency()
por: Ji, Guanxu, et al.
Publicado: (2022)

JMJD3 in the regulation of human diseases
por: Zhang, Xiangxian, et al.
Publicado: (2019)

Inhibition of JMJD6 by 2‐Oxoglutarate Mimics
por: Islam, Md. Sailful, et al.
Publicado: (2021)

Regulation of mouse steroidogenesis by WHISTLE and JMJD1C through histone methylation balance
por: Kim, Sung-Mi, et al.
Publicado: (2010)

Global gene expression profiling of JMJD6- and JMJD4-depleted mouse NIH3T3 fibroblasts
por: Hu, Yu-Jie, et al.
Publicado: (2016)

Jumonji domain containing protein 6 (Jmjd6) modulates splicing and specifically interacts with arginine–serine-rich (RS) domains of SR- and SR-like proteins
por: Heim, Astrid, et al.
Publicado: (2014)

Intronic regulation of Aire expression by Jmjd6 for self-tolerance induction in the thymus
por: Yanagihara, Toyoshi, et al.
Publicado: (2015)

Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response
por: Wang, Kai, et al.
Publicado: (2022)

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer
por: Poulard, Coralie, et al.
Publicado: (2019)

Alternative splicing of CNOT7 diversifies CCR4–NOT functions
por: Chapat, Clément, et al.
Publicado: (2017)

JMJD6 Promotes Colon Carcinogenesis through Negative Regulation of p53 by Hydroxylation
por: Wang, Feng, et al.
Publicado: (2014)

Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer
por: Biswas, Antara, et al.
Publicado: (2020)

JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma
por: Wong, Matthew, et al.
Publicado: (2019)

Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation
por: Farhat, Diana, et al.
Publicado: (2020)

Regulation of T cell proliferation by JMJD6 and PDGF-BB during chronic hepatitis B infection
por: Chen, Cai-Feng, et al.
Publicado: (2014)

Demethylase JMJD6 as a New Regulator of Interferon Signaling: Effects of HCV and Ethanol Metabolism
por: Ganesan, Murali, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7ki159gkhafl5bn5ctb4go74mi